Publications by authors named "Mark Bergman"

Claim this Profile
G
Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer's disease continuum.
Junhao Wen, Zhijian Yang, Ilya M Nasrallah, Yuhan Cui, Guray Erus, Mark Bergman

Transl Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic loci influence patterns of structural covariance in the human brain.
Junhao Wen, Ilya M Nasrallah, Ahmed Abdulkadir, Theodore D Satterthwaite, Zhijian Yang, Mark Bergman

Proc Natl Acad Sci U S A· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics.
Spyridon Bakas, Chiharu Sako, Hamed Akbari, Michel Bilello, Aristeidis Sotiras, Mark Bergman

Sci Data· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional noninvasive in vivo characterization of , 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk).
Saima Rathore, Suyash Mohan, Spyridon Bakas, Chiharu Sako, Chaitra Badve, Mark Bergman

Neurooncol Adv· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cancer Imaging Phenomics Toolkit (CaPTk): Technical Overview.
Sarthak Pati, Ashish Singh, Saima Rathore, Aimilia Gastounioti, Mark Bergman

Brainlesion· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma.
Anahita Fathi Kazerooni, Hamed Akbari, Gaurav Shukla, Chaitra Badve, Jeffrey D Rudie, Mark Bergman

JCO Clin Cancer Inform· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Cancer Imaging Phenomics Toolkit (brain-CaPTk): An Interactive Platform for Quantitative Analysis of Glioblastoma.
Saima Rathore, Spyridon Bakas, Sarthak Pati, Hamed Akbari, Ratheesh Kalarot, Mark Bergman

Brainlesion· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome.
Christos Davatzikos, Saima Rathore, Spyridon Bakas, Sarthak Pati, Mark Bergman

J Med Imaging (Bellingham)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Cheng Ean Chee, Smitha Krishnamurthi, Charles J Nock, Neal J Meropol, Joseph Gibbons, Mark Bergman

Oncologist· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of sequential chemotherapy followed by chemoradiation, surgery, and postoperative chemotherapy for the treatment of stage IIIA/IIIB non-small-cell lung cancer.
Prudence Lam, Stuart Berman, Robert Thurer, Simon Ashiku, Malcolm DeCamp, Mark Bergman

Clin Lung Cancer· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis